Lithuania: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Lithuania

The Lithuanian prophylactic medicaments containing insulin market dropped to $X in 2022, which is down by X% against the previous year. Over the period under review, consumption, however, showed a relatively flat trend pattern. Over the period under review, the market hit record highs at $X in 2014; however, from 2015 to 2022, consumption stood at a somewhat lower figure.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Lithuania

In value terms, prophylactic medicaments containing insulin production declined to $X in 2022 estimated in export price. Overall, production, however, recorded a relatively flat trend pattern. The growth pace was the most rapid in 2013 when the production volume increased by X% against the previous year. Over the period under review, production hit record highs at $X in 2014; however, from 2015 to 2022, production failed to regain momentum.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports from Lithuania

In 2022, the amount of medicaments containing insulin but not antibiotics in measured doses exported from Lithuania reduced dramatically to X tons, which is down by X% compared with the year before. In general, exports faced a abrupt slump. The most prominent rate of growth was recorded in 2015 when exports increased by X%. Over the period under review, the exports reached the peak figure at X tons in 2017; however, from 2018 to 2022, the exports remained at a lower figure.

In value terms, prophylactic medicaments containing insulin exports plummeted to $X in 2022. Overall, exports saw a abrupt descent. The pace of growth appeared the most rapid in 2017 when exports increased by X%. As a result, the exports reached the peak of $X. From 2018 to 2022, the growth of the exports failed to regain momentum.

Exports by Country

The Netherlands (X tons), Germany (X kg) and the Czech Republic (X kg) were the main destinations of prophylactic medicaments containing insulin exports from Lithuania, with a combined X% share of total exports.

From 2012 to 2022, the biggest increases were recorded for the Netherlands (with a CAGR of X%), while shipments for the other leaders experienced more modest paces of growth.

In value terms, the Netherlands ($X) emerged as the key foreign market for medicaments containing insulin but not antibiotics in measured doses exports from Lithuania, comprising X% of total exports. The second position in the ranking was held by Germany ($X), with a X% share of total exports. It was followed by the Czech Republic, with a X% share.

From 2012 to 2022, the average annual rate of growth in terms of value to the Netherlands amounted to X%. Exports to the other major destinations recorded the following average annual rates of exports growth: Germany (X% per year) and the Czech Republic (X% per year).

Export Prices by Country

In 2022, the average prophylactic medicaments containing insulin export price amounted to $X per ton, picking up by X% against the previous year. In general, the export price posted buoyant growth. As a result, the export price reached the peak level and is likely to continue growth in the immediate term.

Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was the Netherlands ($X,102 per ton), while the average price for exports to Belarus ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to the Netherlands (X%), while the prices for the other major destinations experienced a decline.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports into Lithuania

Prophylactic medicaments containing insulin imports into Lithuania contracted notably to X tons in 2022, with a decrease of X% on the year before. Overall, imports continue to indicate a pronounced reduction. The most prominent rate of growth was recorded in 2015 with an increase of X%. Imports peaked at X tons in 2017; however, from 2018 to 2022, imports failed to regain momentum.

In value terms, prophylactic medicaments containing insulin imports contracted rapidly to $X in 2022. In general, imports continue to indicate a drastic downturn. The most prominent rate of growth was recorded in 2020 with an increase of X% against the previous year. Over the period under review, imports reached the peak figure at $X in 2017; however, from 2018 to 2022, imports stood at a somewhat lower figure.

Imports by Country

In 2022, Latvia (X tons) constituted the largest supplier of prophylactic medicaments containing insulin to Lithuania, with a X% share of total imports. Moreover, prophylactic medicaments containing insulin imports from Latvia exceeded the figures recorded by the second-largest supplier, Germany (X tons), twofold. The Czech Republic (X tons) ranked third in terms of total imports with an X% share.

From 2012 to 2022, the average annual rate of growth in terms of volume from Latvia totaled X%. The remaining supplying countries recorded the following average annual rates of imports growth: Germany (X% per year) and the Czech Republic (X% per year).

In value terms, Latvia ($X), Germany ($X) and the Czech Republic ($X) constituted the largest prophylactic medicaments containing insulin suppliers to Lithuania, together comprising X% of total imports.

Among the main suppliers, Latvia, with a CAGR of X%, saw the highest rates of growth with regard to the value of imports, over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

In 2022, the average prophylactic medicaments containing insulin import price amounted to $X per ton, stabilizing at the previous year. Overall, the import price, however, showed a mild decrease. The growth pace was the most rapid in 2014 when the average import price increased by X% against the previous year. As a result, import price reached the peak level of $X per ton. From 2015 to 2022, the average import prices remained at a lower figure.

There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was Slovenia ($X per ton), while the price for the Czech Republic ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Hungary (X%), while the prices for the other major suppliers experienced mixed trend patterns.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :